Inventor · disambiguated record
Michael Hahn
Also filed as: HAHN MICHAEL · HAHN MICHAEL G · HAHN MICHAEL-GOTTFRIED
39 granted patents·26 pending applications·232 citations·filing 1996–2024
97Inventor score
Top patents by PatentIndex Score
65 records- 0195US7705043B2Substituted aminodicarboxylic acid derivatives having pharmaceutical propertiesBAYER SCHERING PHARMA AG·Filed 2006·Granted Apr 27, 2010·50 cites·11 claims
- 0293US8796335B2Branched 3-phenylpropionic acid derivatives and their useHAHN MICHAEL·Filed 2012·Granted Aug 5, 2014·17 cites·1 claims
- 0393US7329777B2Methods for treating heart failure, thromboembolic disorders, and pulmonary fibrosisBAYER AG·Filed 2005·Granted Feb 12, 2008·29 cites·12 claims
- 0489US8981104B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2013·Granted Mar 17, 2015·13 cites·12 claims
- 0589US7998988B2Biphenyl compounds useful in the treatment or prevention of cardiovascular disordersBAYER SCHERING PHARMA AG·Filed 2006·Granted Aug 16, 2011·15 cites·8 claims
- 0687US10023528B2Branched 3-phenylpropionic acid derivatives and their useBAYER IP GMBH·Filed 2016·Granted Jul 17, 2018·4 cites·8 claims
- 0787US8217063B2Lactam-substituted dicarboxylic acids and use thereofHAHN MICHAEL·Filed 2008·Granted Jul 10, 2012·6 cites·11 claims
- 0886US8673903B2Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereofHUEBSCH WALTER·Filed 2011·Granted Mar 18, 2014·9 cites·7 claims
- 0984US10414765B2Substituted perhydropyrrolo[3,4-c]pyrrole derivatives and the use of sameBayer Pharma AG·Filed 2016·Granted Sep 17, 2019·4 cites·8 claims
- 1084US10259776B2Branched 3-phenylpropionic acid derivatives and their useBAYER IP GMBH·Filed 2018·Granted Apr 16, 2019·2 cites·1 claims
- 1184US9018414B2Substituted 3-phenylpropionic acids and the use thereofBAYER IP GMBH·Filed 2013·Granted Apr 28, 2015·6 cites·16 claims
- 1283US7985876B2Substituted dibenzoic acid derivatives and use thereofBAYER SCHERING PHARMA AG·Filed 2008·Granted Jul 26, 2011·6 cites·9 claims
- 1382US10759794B22-phenyl-3-(piperazinomethyl)imidazo[1,2-A]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disordersBayer Pharma AG·Filed 2016·Granted Sep 1, 2020·3 cites·31 claims
- 1482US9688636B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2015·Granted Jun 27, 2017·3 cites·8 claims
- 1581US9018258B2Substituted 1-benzylcycloalkylcarboxylic acids and the use thereofLAMPE THOMAS·Filed 2011·Granted Apr 28, 2015·6 cites·10 claims
- 1681US8183271B2Tetrazole derivatives and their use for the treatment of cardiovascular diseasesBARTEL STEPHAN·Filed 2006·Granted May 22, 2012·6 cites·8 claims
- 1779US10053428B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2017·Granted Aug 21, 2018·2 cites·34 claims
- 1879US6939989B2Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseasesBAYER AG·Filed 2002·Granted Sep 6, 2005·12 cites·8 claims
- 1977US11377417B2Branched 3-phenylpropionic acid derivatives and their useBAYER IP GMBH·Filed 2020·Granted Jul 5, 2022·0 cites·6 claims
- 2076US9498480B2Substituted azabicycles and use thereofBAYER IP GMBH·Filed 2013·Granted Nov 22, 2016·3 cites·6 claims
- 2176US9387203B2Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereofBayer Pharma AG·Filed 2013·Granted Jul 12, 2016·3 cites·9 claims
- 2276US6939990B2Derivatives of dicarboxylic acid having pharmaceutical propertiesBAYER AG·Filed 2002·Granted Sep 6, 2005·8 cites·12 claims
- 2376US2025154175A1Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2024·Application pending·0 cites
- 2475US11098063B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2018·Granted Aug 24, 2021·1 cites·13 claims
- 2575US8987256B2Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereofHAHN MICHAEL·Filed 2009·Granted Mar 24, 2015·2 cites·10 claims
- 2674US8609727B2Dicarboxylic acid derivatives and their useBARTEL STEPHAN·Filed 2006·Granted Dec 17, 2013·2 cites·9 claims
- 2773US9309198B2N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclaseBayer Pharma AG·Filed 2013·Granted Apr 12, 2016·2 cites·10 claims
- 2873US8173704B2Difluorophenol derivatives and their useBARTEL STEPHAN·Filed 2006·Granted May 8, 2012·2 cites·6 claims
- 2973US7700653B2Halogen-substituted aminodicarboxylic acid derivativesBAYER SCHERING PHARMA AG·Filed 2005·Granted Apr 20, 2010·1 cites·4 claims
- 3072US12138256B2Treatment of cardiopulmonary disordersBAYER AG·Filed 2023·Granted Nov 12, 2024·0 cites·30 claims
- 3172US10189856B2Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)HIRTH DIETRICH CLAUDIA·Filed 2011·Granted Jan 29, 2019·4 cites·7 claims
- 3270US8642592B2Oxo-heterocyclically substituted alkyl carboxylic acids and use thereofLAMPE THOMAS·Filed 2010·Granted Feb 4, 2014·2 cites·10 claims
- 3369US8168821B2Cyclopropylacetic acid derivatives and use thereofBECKER EVA-MARIA·Filed 2006·Granted May 1, 2012·2 cites·6 claims
- 3469US7067694B2Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseasesBAYER AG·Filed 2002·Granted Jun 27, 2006·3 cites·9 claims
- 3569US2025090519A1Treatment of cardiopulmonary disordersBAYER AG·Filed 2024·Application pending·0 cites
- 3667US12180227B2Diazabicyclic substituted imidazopyrimidines and their use for the treatment of breathing disordersBAYER AG·Filed 2021·Granted Dec 31, 2024·0 cites·10 claims
- 3766US2019185415A1Branched 3-phenylpropionic acid derivatives and their useBAYER IP GMBH·Filed 2018·Application pending·0 cites
- 3864US2014309307A1Branched 3-phenylpropionic acid derivatives and their useBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 3963US2025057828A1Combination of an a2-adrenoceptor subtype c (alpha-2c) antagonist with a norepinephrine reuptake inhibitor for the treatment of sleep apneaBAYER AG·Filed 2022·Application pending·0 cites
- 4063US2025049803A1Combination of a task1/3 channel blocker with a norepinephrine reuptake inhibitor for the treatment of sleep apneaBAYER AG·Filed 2022·Application pending·0 cites
- 4163US2025074899A1A2-adrenoceptor subtype c antagonists for the treatment of sleep apneaBAYER AG·Filed 2023·Application pending·0 cites
- 4263US2025057846A1Combination of a task1/3 channel blocker with a muscarinic receptor antagonist for the treatment of sleep apneaBAYER AG·Filed 2022·Application pending·0 cites
- 4362US2025049788A12,3-dihydrobenzo [b][1, 4]dioxin-2-ylmethyl)piperazin-1-yl derivates for the treatment of sleep apneaBAYER AG·Filed 2023·Application pending·0 cites
- 4459US2022259228A1Substituted diazahetero-bicyclic compounds and their useBAYER AG·Filed 2021·Application pending·0 cites
- 4557US10265314B2SGC stimulators in combination with additional treatment for the therapy of cystic fibrosisBayer Pharma AG·Filed 2014·Granted Apr 23, 2019·0 cites·8 claims
- 4656US2025281480A1Pharmaceutical dry powder inhalation formulationBAYER AG·Filed 2022·Application pending·0 cites
- 4756US2024000767A1Combination of an alpha2-adrenoceptor subtype c (alpha-2c) antagonist with a task1/3 channel blocker for the treatment of sleep apneaBAYER AG·Filed 2021·Application pending·0 cites
- 4855US7619077B2Nucleic acids encoding a galacturonosyl tranferase enzyme (GALAT1) from arabidopsisUNIV GEORGIA RES FOUND·Filed 2004·Granted Nov 17, 2009·1 cites·6 claims
- 4954US2022016113A1?2-adrenoceptor subtype c (alpha-2c) antagonists for the treatment of sleep apneaBAYER AG·Filed 2019·Application pending·0 cites
- 5053US2025057845A1Combination of a task1/3 channel blocker with a p2x3 receptor antagonist for the treatment of sleep apneaBAYER AG·Filed 2020·Application pending·0 cites
Showing the top 50 of 65 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Michael Hahn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →